Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 23, 2024
Gliomas,
particularly
glioblastoma
(GBM),
are
the
most
common
and
aggressive
primary
brain
tumors
in
adults,
characterized
by
high
malignancy
frequent
recurrence.
Despite
standard
treatments,
including
surgery,
radiotherapy,
chemotherapy,
prognosis
for
GBM
remains
poor,
with
a
median
survival
of
less
than
15
months
five-year
rate
below
10%.
Tumor
heterogeneity
resistance
to
treatment
create
significant
challenges
controlling
glioma
progression.
Therefore,
there
is
an
urgent
need
new
therapeutic
targets
strategies.
This
study
investigates
role
Disulfidptosis,
recently
discovered
form
programmed
cell
death,
gliomas.
Unlike
apoptosis
necrosis,
Disulfidptosis
driven
abnormal
accumulation
intracellular
disulfide
bonds,
leading
protein
misfolding
cytoskeletal
collapse,
cancer
cells
metabolic
dysregulation.
We
aim
explore
how
respond
identify
potential
analyzing
gliomas
at
single-cell
level
using
RNA
sequencing
(scRNA-seq).
scRNA-seq
data
from
patients
were
analyzed
uncover
differences
ferroptosis-related
pathways,
iron
metabolism
lipid
peroxidation.
Cellular
subpopulations
within
profiled
assess
their
sensitivity
underlying
mechanisms.
Survival
analysis
was
conducted
evaluate
clinical
relevance
Disulfidptosis-related
gene
expression.
Multiple
exhibit
varying
sensitivities
influenced
properties.
Dysregulated
antioxidant
mechanisms
identified
as
key
factors
impacting
sensitivity.
Glioma
microenvironment
signaling
pathways
also
play
regulating
Disulfidptosis.
These
findings
suggest
that
activating
may
provide
novel
strategies
overcome
offers
insights
into
progression
highlights
its
target.
By
leveraging
data,
research
uncovers
tumor
identifies
specific
populations
resistant
pave
way
personalized
improve
outcomes
patients.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 29, 2024
Ovarian
carcinoma
(OC)
is
a
prevalent
gynecological
malignancy
associated
with
high
recurrence
rates
and
mortality,
often
diagnosed
at
advanced
stages.
Despite
advances
in
immunotherapy,
immune
exhaustion
remains
significant
challenge
achieving
optimal
tumor
control.
However,
the
exploration
of
intratumoral
heterogeneity
malignant
epithelial
cells
ovarian
cancer
microenvironment
still
limited,
hindering
our
comprehensive
understanding
disease.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 15, 2025
The
metabolism
of
stearoyl-GPE
plays
a
key
role
in
the
liver
metastasis
gastric
cancer.
This
investigation
delves
into
mechanisms
underlying
intricate
tumor
microenvironment
(TME)
heterogeneity
triggered
by
stearoyl
cancer
with
(LMGC),
offering
novel
perspectives
for
LMGC.
Utilizing
Mendelian
randomization,
we
determined
that
significantly
contributes
to
progression
(GC).
Following
this,
bulk
transcriptome
analyses
and
single-cell
multiomics
techniques
investigate
roles
metabolism-related
genes,
particularly
NCOA4,
regulating
LMGC
TME.
Our
analysis
highlights
crucial
modulating
complex
LMGC,
impacting
monocyte
cells.
Through
sequencing
spatial
transcriptomics,
have
identified
metabolic
genes
specific
within
cell
population,
including
NCOA4.
Regarding
relationship
between
ferroptosis,
metabolism,
findings,
it
is
plausible
pathways
intersect
involved
ferroptosis.
Ferroptosis,
characterized
iron-dependent
lipid
peroxidation,
represents
regulated
form
death.
activity
Stearoyl-CoA
desaturase
(SCD),
critical
enzyme
has
been
associated
modulation
composition
susceptibility
Furthermore,
integral
cellular
processes
related
oxidative
stress
both
which
are
significant
factors
context
study
enhances
understanding
ferroptosis
promoting
its
regulation
heterogeneity.
In
addition,
this
deeper
dynamics
provides
basis
development
better
interventions
combat
metastasis.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 4, 2024
Breast
cancer,
due
to
resistance
standard
therapies
such
as
endocrine
therapy,
anti-HER2
therapy
and
chemotherapy,
continues
pose
a
major
health
challenge.
A
growing
body
of
research
emphasizes
the
heterogeneity
plasticity
metabolism
in
breast
cancer.
Because
differences
subtypes
exhibit
bias
toward
metabolic
pathways,
targeting
mitochondrial
inhibitors
shows
great
potential
stand-alone
or
adjuvant
cancer
therapies.
Multiple
therapeutic
candidates
are
currently
various
stages
preclinical
studies
clinical
openings.
However,
specific
have
been
shown
face
multiple
challenges
(e.g.,
single
therapies,
structure
enzymes,
etc.),
combining
with
pathways
may
be
necessary.
In
this
paper,
we
review
critical
role
functions,
including
oxidative
phosphorylation
(OXPHOS),
tricarboxylic
acid
cycle,
fatty
amino
metabolism,
reprogramming
cells.
addition,
outline
impact
dysfunction
on
different
aiming
provide
additional
ideas
for
development
improve
efficacy
existing
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 9, 2025
Adenocarcinoma
of
the
esophagogastric
junction
(AEGJ)
is
a
highly
aggressive
tumor
that
frequently
metastasizes
to
liver.
Understanding
cellular
and
molecular
mechanisms
drive
this
process
essential
for
developing
effective
therapies.
We
employed
single-cell
RNA
sequencing
analyze
heterogeneity
microenvironmental
landscape
in
patients
with
AEGJ
liver
metastases.
This
approach
enabled
us
characterize
diverse
cell
populations
involved
metastatic
process.
Our
analysis
revealed
significant
involvement
fibroblasts
mural
cells
metastasis.
identified
specific
fibroblast
type
metastasis
observed
distinct
gene
expression
patterns
between
adenocarcinoma
other
stomach
adenocarcinomas.
study
demonstrated
high
SFRP2
pericyte
during
AEGJ.
The
incorporation
GEO,
TCGA,
immunofluorescence
staining
enhanced
our
study.
High
pericytes
may
influence
vascular
stability
angiogenesis
through
Wnt
pathway.
provides
novel
insights
into
interactions
underlie
Targeting
subtype
or
influencing
offer
new
therapeutic
strategies
combating
tumor.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 17, 2025
Breast
cancer
(BC)
is
one
of
the
most
prevalent
malignant
tumors
among
women
globally,
with
number
cases
accounting
for
even
more
than
1/3
all
tumor
patients
in
women.
Recent
studies
have
found
that
incidence
BC
increasing
every
year.
Despite
great
progress
made
treatment,
characteristics
cells,
such
as
strong
immune
evasion,
easy
recurrence
and
drug
resistance,
are
still
main
reasons
limiting
survival
patients.
Epigenetics
becoming
an
important
method
to
reveal
development
cancer,
mainly
through
study
DNA
methylation,
histone
modification,
chromatin
structure
changes
non-coding
RNA.
In
addition,
researchers
epigenetic
markers
potential
early
detection
personalized
treatment
BC.
Inhibitors
targeting
epigenetically
modified
enzymes
effective
treating
a
wide
range
provide
significant
patient
quality
life.
Therefore,
this
review
will
comprehensively
summarize
role
modifications
development.
Second,
paper
focus
on
summarizing
how
induce
formation
microenvironment
(TIME)
Targeting
mechanism
action
provides
new
perspectives
unravel
complex
process
development,
while
paving
way
novel
diagnostic
therapeutic
targets.
future,
by
integrating
multi-omics
data
enable
deeper
understanding
pathogenesis
BC,
we
be
able
promote
overall
precision
medicine.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 16, 2024
Acute
myeloid
leukemia
(AML)
is
a
hematologic
tumor
with
poor
prognosis
and
significant
clinical
heterogeneity.
By
integrating
transcriptomic
data,
single-cell
RNA
sequencing
data
independently
collected
this
study
aims
to
identify
key
genes
in
AML
establish
prognostic
assessment
model
improve
the
accuracy
of
prediction.
Aging,
Journal Year:
2024,
Volume and Issue:
unknown
Published: June 18, 2024
Background:
Breast
cancer,
comprising
15%
of
newly
diagnosed
malignancies,
poses
a
formidable
global
oncological
challenge
for
women.
The
severity
this
malady
stems
from
tumor
infiltration,
metastasis,
and
elevated
mortality
rates.
Disulfidptosis,
an
emerging
cellular
demise
mechanism,
presents
promising
avenue
precision
therapy.
Our
aim
was
to
construct
prognostic
framework
centered
on
long
non-coding
RNAs
(lncRNAs)
associated
with
disulfidptosis,
aiming
guide
the
strategic
use
clinical
drugs,
enhance
precision,
advance
immunotherapy
prognosis
assessment.
Methods:
We
systematically
analyzed
TCGA-BRCA
dataset
identify
disulfidptosis-linked
lncRNAs.
Employing
co-expression
analysis,
we
discerned
significant
relationships
between
disulfidptosis-associated
genes
Identified
lncRNAs
underwent
univariate
Cox
regression
validation
through
LASSO
regression,
culminating
in
identification
eight
signature
using
multivariate
proportional
risk
model.
Then,
utilized
selected
build
prediction
models.
Results:
DAL
model
exhibited
outstanding
efficacy,
establishing
itself
as
autonomous
determinant
breast
cancer
prognosis.
It
adeptly
differentiated
low
high-risk
patient
cohorts,
individuals
experiencing
significantly
abbreviated
survival
durations.
Notably,
these
cohorts
displayed
marked
discrepancies
markers
microenvironment
attributes.
Conclusions:
has
performed
well
assessment
by
combining
it
other
traditional
indicators
Nomogram
plots
gene
expression
data
calculate
patients'
disease
scores.
This
approach
provides
new
ideas
decision
support
personalized
treatment
decisions
patients
different
levels.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 16, 2024
Glycosyltransferase-associated
genes
play
a
crucial
role
in
hepatocellular
carcinoma
(HCC)
pathogenesis.
This
study
investigates
their
impact
on
the
tumor
microenvironment
and
molecular
mechanisms,
offering
insights
into
innovative
immunotherapeutic
strategies
for
HCC.